
MIRUM PHARMACEUTICALS INC
MIRMNASDAQ🏆 #1131 by market capEarnings Nov 3US Equity
$100.21▲ $2.02 (+2.02%)
Live1h▲ 0.5%
24h▲ 2.0%
7d▼ 5.2%
14d▼ 6.9%
30d▼ 15.8%
1y▲ 54.9%
🏦Market Cap
$6.11B
Small Cap
📈Revenue Growth (YoY)
+54.7%
High Growth
📊Gross Margin
81.7%
High
💵FCF Margin
-74.1%
Thin
⚖️P/S Ratio
9.7x
Elevated
Otter Score
60
Fair
📊
Analyst Ratings
Price
$100.21
Total
18
Raised
0
Lowered
0
Avg PT
$138.30
H / L
$165 / $118
| Institution | Action | Rating | Date |
|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-08-06 |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-06 |
RBC Capital | Reiterated | Outperform | 2026-07-07 |
JP Morgan | Reiterated | Overweight | 2026-07-02 |
Morgan Stanley | Reiterated | Overweight | 2026-06-11 |
Baird | Reiterated | Outperform | 2026-05-07 |
TD Cowen | Reiterated | Buy | 2026-05-07 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-07 |
Stifel | Reiterated | Buy | 2026-04-29 |
Leerink Partners | Reiterated | Outperform | 2026-02-26 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-08 |
Raymond James | Reiterated | Strong Buy | 2025-08-07 |
JMP Securities | Reiterated | Market Outperform | 2025-08-07 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-24 |
Citigroup | Reiterated | Buy | 2024-11-13 |
HC Wainwright& Co. | Reiterated | Buy | 2023-06-15 |
SVB Leerink | Reiterated | Outperform | 2023-01-10 |
Guggenheim | Reiterated | Buy | 2020-09-09 |
One row per institution, most recent rating